Medicare AdvantageCoverageMedium impact
MA11.101, Nucleoplasty
Independence Blue Cross·Orthopedics, Neurosurgery, Pain Management·Medical Policy
Effective date
Jan 21, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.101 regarding Nucleoplasty has been reissued with an effective date of January 21, 2026. This is a policy update for a minimally invasive spine procedure, though specific coverage or billing changes are not detailed in the summary.
Action Required
By January 21, 2026: Billing team should review the full MA11.101 Nucleoplasty policy at the provided URL to understand specific coverage changes, prior authorization requirements, or billing guidelines that may affect nucleoplasty procedures. Update billing protocols and staff training as needed based on the detailed policy content.